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Efforts to improve the detection of Alzheimer's disease (AD) and increase diagnosis rates 39 particularly at earlier stages to manage the 'impending burden' of an 'ageing population', 40 drives current UK healthcare policy initiatives and scientific agendas (Lock 2013: 22) . 41
According to Golomb et al., (2004) , 'explosion of interest [in AD] reflects a shift in dementia 42 research away from established disease and toward early diagnosis' (pp. 353). Scientific 43 research is currently dominated by efforts to detect biomarkers, the earliest physical signs of 44 the disease (see Zetterberg 2011) and since age is the greatest risk factor for developing AD, 45 healthcare policy initiatives have also emerged in recent years, which seek to improve 46 diagnosis rates in the older population. Such initiatives implemented in the National Health 47 Service (NHS) include pay-for-performance schemes such as the GP Quality Outcomes 48 M A N U S C R I P T
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In the drive towards early diagnosis to manage the risks of an ageing population, the 51 development of new techniques and technologies to identify genetic risk factors and detect 52 biomarkers, reflects a larger transition in contemporary biomedicine which Clarke ways of approaching and managing the condition remain primarily within a biomedical 66 framework (see Lock 2013) . 67
68
As a result of the political and scientific focus and government funding towards determining 69 cause, cure and prevention of AD, care (with respect to non-biomedical intervention in 70 healthcare practice), as an alternative for managing AD has been relatively overlooked (Lock 71 2013) . In the UK context, the publically funded NHS in recent years has faced (and continues 72 to face) financial cuts with the majority of NHS trusts experiencing rising debt. Social care in 73 the UK has also seen a marked decline in terms of funding with detrimental consequences forM A N U S C R I P T
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4 2016). The curative model for managing AD as it sustains the hegemony of the biomedical 76 framework both impacts individuals' experiences of ageing and memory loss and has also led 77 to a marked decline in the funding of basic care services. 78
79
The complexities of early diagnosis 80
81
Despite the focus in research and policy on detecting AD at earlier stages, early diagnosis is a 82 contested issue in part because the condition is nosologically contested. AD is an elusive 83 phenomenon and the diagnosis process is a complex endeavour; symptoms associated with 84 cognitive decline are difficult to separate from those of normal ageing processes and there 85 remains no cure or adequate treatment options (see Gubrium 1986; Lock, 2013) . Due to the 86 complexity of AD's aetiology, Lock (2013) is especially critical of increased efforts in 87 biomedicine to prevent AD and establish early diagnosis. Prevention strategies in research are 88 grounded on the conception that they will lead to an improved understanding of AD's 89
aetiology. Yet as Lock shows, despite increased attention in research and policy on disease 90 prevention, uncertainty around aetiology prevails. 91
92
Early diagnosis is further contested as it raises questions around for whom exactly it is better 93 to know. The hopeful discourse around early diagnosis highlights the importance of enabling 94 individuals to plan and prepare for their future. For example, proceeding with care 95 arrangements and seeking advice regarding power of attorney or a living will (see Boenink 
importance of a caring model for managing AD, this approach is difficult to uphold (Apesoa-126
Varano, Barker and Hinton 2011). As physicians attempt to manage the 'symbolic power of 127 cure' more generally with respect to dementia, care remains a 'secondary and temporary' 128 articulation (pp. 1469). Given the limited treatment and care options and no cure for the 129 condition, the hegemony of the biomedical model as it drives early diagnosis, further 130 increases the uncertainties and anxieties felt by patients and their families (Lock 2013) . 131
132
It is therefore well established that early diagnosis is contested and entangled in a wider 133 discourse of cure versus care. Yet, exactly how practitioners account for and negotiate the 134 potential repercussions of early diagnosis with respect to both the complexity of expectations 135 and anxieties concerning diagnosis, and the underfunding of basic care services, requires 136 critical examination. This article examines the ways in which despite the hopeful discourse of 137 early diagnosis, it has the potential to (re)produce patients' fears and anxieties concerning the 138 future as the prevailing biomedical model plays out in patient-practitioner encounters. Yet, 139 the article also captures the conflicts and contradictions concerning early diagnosis inherent 140 to practitioners' accounts as they convey a sense of ambivalence: they simultaneously 141 recognise the low expectations entangled in diagnosis and yet the 'truth' of cognitive decline 142 is (re)produced, maintaining the dominant biomedical model for managing AD. Focussing in 143 particular on the Science and Technology Studies (STS) literature on the sociology of 'low' 144 expectations, this article examines the ways in which the hopeful future orientated discourse 145 of early diagnosis is negotiated in the clinic and in doing so, highlights its affective 146 dimensions: including hopelessness, uncertainty, anticipation and ambivalence. Observations of consultations exploring how the complexities of diagnosis were negotiated in 218 practice were recorded in handwritten notes and both interview transcripts and fieldnotes 219 were analysed thematically. I analysed data manually to manage and make sense of emergent 220 themes without becoming overwhelmed by quantity and scope. By adopting an ethnographic 221 approach, I investigated how AD was 'brought into being' within a particular set of 222 healthcare practices; revealing the 'situated rationality of action' (Murphy and DingwallM A N U S C R I P T
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I begin the analysis by highlighting the ways in which particular discursive representations of 226
Alzheimer's disease emerge in the space of the clinic creating anxieties for patients and their 227 families. The stigma attached to AD prevails which was witnessed across memory clinic 228 encounters and confirmed across practitioners' accounts as they discussed moments where 229 patients resisted diagnosis, fearing a future confined to institutional care. As practitioners 230 recounted, the affective consequences of diagnosis including fear and anxiety have the 231 potential to be (re)produced by early diagnosis. Elucidating the low expectations or 232 hopelessness around early diagnosis, I develop the analysis to capture practitioners' internal 233 conflicts concerning the benefit of early diagnosis for patients and their families. Practitioners 234 struggle against feelings of ambivalence as they recognise that it enables patients and their 235 families to prepare for the future and yet they are simultaneously concerned that it has the 236 potential to cause futures filled with uncertainty and anticipation. This sense of ambivalence 237 is complicated further as the prevailing model for managing AD has led to the underfunding 238 of basic care resources in the UK. The article concludes by arguing that the tensions and 239 contradictions inherent to practitioners' accounts provide an important and significant 240 perspective for troubling the dominant biomedical model for managing AD. It is not always 241 beneficial for patients to 'know' since dominant perceptions of the 'disease' are framed 242 primarily around loss of self, restricting the space for other meanings of memory loss to co-243 exist, whilst care (non-biomedical intervention) is simultaneously undervalued and 244 underfunded as a viable alternative for managing the disease. 245
Knowing and its consequences 247
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In the following section, I highlight the ways in which practitioners accounted for fear and 251 anxiety entangled in diagnosis more generally. I then go on to capture how the fears and 252 anxieties concerning diagnosis are in conflict with the hopeful promissory claims of early 253 diagnosis. As accounted for by practitioners, the 'truth' of cognitive decline has the potential 254 to (re)produce the uncertainties and anxieties that it aims to resolve, closing off and 255 restricting the co-existence of other meanings and experiences of memory loss. 256
257
For patients and their families, the prospect of Alzheimer's disease overall, has the potential 258 to create huge anxiety and fear, as it remains a stigmatised condition (see Beard 2013) . As 259
Consultant Psychiatrist 1 explains, 260 261 'There is still an awful lot of stigma in the population generally and amongst 262 individuals as to the nature of it [AD], a lot of fear' (Interview Consultant 263
Psychiatrist 1).' 264 265
Such fearful anticipation of AD given its stigmatisation and association with antiquated 266 assumptions regarding madness and senility was witnessed during observations of 267 consultations. Patients would often adopt the metaphor 'doolally' to account for their 268 symptoms and concerns following assessment, and patients would thank practitioners for not 269 laughing or apologising for how 'stupid' they considered themselves. Practitioners discussed 270 and reflected on the negative discursive constructs entangled in diagnosis during team 271 meetings, particularly in relation to the ways in which patients approached diagnostic 272 In this case, the patient's refusal to attend assessment and diagnostic appointments was driven 283 by the fearful anticipation around the meaning of diagnosis, of which there remains a great 284 deal of negativity. As a result, the complexities entangled in the meaning of memory loss, 285 As these extracts elucidate, the process of diagnosis and assessment had the potential to 318 intensify feelings of uncertainty and anxiety, which as I show, was complicated further by 319 early diagnosis. Across the memory clinics, practitioners predominantly practised 'wilful 320 resistance' to early diagnosis and the kinds of hopeful promissory claims it enacts, they 321 considered earlier detection to intensify feelings of anxiety about living with AD into the 322 future. As Consultant Psychiatrist 1 asked during interview, 'are we just giving patients moreM A N U S C R I P T A C C E P T E D 
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT about their future(s). As Consultant Psychiatrist 2 suggested during interview, 'early 375 diagnosis is so important so that you can allow people to make decisions about their future 376 themselves'. Echoed further by Clinical Psychologist 1, 'to make sense of their experiences, 377
to plan and change things accordingly' whilst 'they still had capacity' (Observation Notes 378 MDT Nunmill Hospital). Whilst it is of course unsurprising that practitioners upheld the 379 primacy of the diagnostic act since they are primarily trained to provide diagnosis and 380 treatment, they also struggled against feelings of ambivalence about the consequences of 381 privileging early diagnosis in the clinic. As a result, practitioners were not simply passive 382 respondents to the privilege of the biomedical framework for managing AD (see Rose 2007) . 383
They recognised that early diagnosis is complex and should be approached with caution 384 thereby demonstrating their own internal conflicts and contradictions concerning the benefits 385
of early diagnosis. The following extracts from interviews with Memory Nurse 2 and 386
Memory Nurse 3 capture this sense of ambivalence. 387
388
"Well that's a bit of a hornet's nest, isn't it? I suppose there's two schools of thought 389 and I've got a foot in each circle, which is a bit, I am sitting on the fence a bit really. I 390 think because if people want to know because they've got memory problems and it's 391 impacting on their day to day life, yeah they need to know… they need to plan what to 392 do, they need to be able to sort themselves …but then you see it and you think well 393 you're gonna have to live with this diagnosis for a long, long time…I don't think 394 everyone's aware how emotional that's gonna be for the person involved and their 395 relatives… and I don't think that this big drive really takes [that] into account" 396 (Interview Memory Nurse 2). 397
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In 'sitting on the fence' Memory Nurse 2 establishes their sense of ambivalence. They 399 acknowledge that individuals may find a diagnosis helpful to make sense of their experiences 400 of memory loss 'day-to-day' and to make practical preparations for the future. Yet, in doing 401 so it has the potential to efface the emotional and affective consequences of diagnosis. (2013) 'downplaying' the more 'tangential', invisible and affective consequences of promoting early 573 diagnosis, which is uncertain and complex (Michael 2000: 30) . Although this uncertainty is 574 not necessarily a point unique to AD, practitioners attest that given the difficulty in 575 determining a treatment or cure for AD, care as an alternative and viable option for managing 576 the disease, is often overlooked within the prevailing (bio)medical model. Practitioners iterate 577 that early diagnosis closes off 'care into the future', both in terms of the work involved in 578 handling a diagnosis, and also in terms of resources. Despite the prevailing (bio)medical 579 model through which AD is positioned, the consequences of the underfunding of social care 580 in the UK as early diagnosis is privileged in research and policy, is often at the core of 581 practitioners' concerns. Not only does early diagnosis therefore have the potential to 582 (re)produce the anxieties and anticipations about the future with AD for patients, it also 583 creates anxieties for practitioners. 584
Yet, this article has not only dealt with the repercussions of the prevailing biomedical model 585 for managing AD entangled within a wider discussion of the cure versus care debate, it has 586 also captured the tensions and contradictions inherent to practising early diagnosis. Whilst a 587 number of practitioners attest that diagnosis may enable patients to 'prepare for their future' 588 they simultaneously recognise that a diagnosis has affective and emotional consequences 589 which may be difficult to negotiate. Dealing with early diagnosis therefore requires 590 practitioners to manage their own feelings of ambivalence. Practitioners themselves struggle 591 to deal with the benefits of early diagnosis given its ambiguity; it has the potential to create a 592 future filled with uncertainty and anxiety as it restricts the co-existence of other meanings of 593 memory loss beyond 'loss of self', and reinforces the construction that 'cognition is the 594 M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT of ambivalence, this article draws together the consequences of the cure versus care debate in 597 relation to its affective dimensions or 'low' expectations. This is significant in that it 598 addresses the gap in the literature which pertains to the ways in which practitioners negotiate 599 the complexities of emotions or low expectations in the clinic regarding a future with AD, 600 whilst simultaneously expressing their own feelings of ambivalence. 601
Yet, despite practitioners accounting for the low expectations enacted by early diagnosis and 603 in doing so dealing with their own sense of ambivalence, the dominance of the biomedical 604 model with respect to diagnosis is maintained and (re)produced. To negotiate this the trainee 605 psychiatrist suggested that it may be useful to protect patients by giving them a 'few years not 606 knowing', yet in practice, practitioners are constrained by the drive in healthcare policy to 607 diagnose AD at earlier stages through pay-for-performance schemes such as those outlined in 608 the introduction. Further research could examine the impact of these initiatives on the 609 affective dimensions of early diagnosis and the ways in which the biomedical model is 610 continually upheld and privileged despite practitioners constructing (temporary) articulations 611 of care (Apesoa-Varona, Barker and Hinton 2011). 612
613
The sense of ambivalence conveyed by practitioners as they negotiate the narrative of 'truth' 614 and 'hope' as described by Moreira (2010) is previously unaccounted for in literature, which 615 critically engages with the complexities of the cure versus care debate. Such ambivalence 616 also creates a space in which stakeholders may need to contemplate and debate the 617 privileging of early diagnosis: practitioners are not simply passive respondents to the 618 processes of (bio)medicalisation which circulate across practitioner-patient encounters. In this 619 sense, further research is also required to account for patients' and family members'M A N U S C R I P T
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facing the NHS and the underfunding of social care in the UK. Overall, this article hopes to 622 offer a brief insight into early diagnosis as it shifts the overlooked expectations of patients 623 and concerns of practitioners; producing anxieties and uncertainties that it is expected to 624 resolve. In privileging the biomedical model for framing and making sense of AD, 625 policymakers should pay due attention to the affective labour at work, and the complexities 626 of a healthcare system through which diagnosis is privileged and care underfunded. In doing 627 so, encouraging an everyday sensibility to managing the ambiguities of AD than the 628 privileging of early diagnosis allows in the space of the clinic. 
